BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 34284051)

  • 21. Metastasis, risk factors and prognostic significance of splenic hilar lymph nodes in gastric adenocarcinoma.
    Chen XL; Yang K; Zhang WH; Chen XZ; Zhang B; Chen ZX; Chen JP; Zhou ZG; Hu JK
    PLoS One; 2014; 9(6):e99650. PubMed ID: 24915065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histopathological regression of gastric adenocarcinoma after neoadjuvant therapy: a critical review.
    Neves Filho EH; de Sant'Ana RO; Nunes LV; Pires AP; da Cunha MD
    APMIS; 2017 Feb; 125(2):79-84. PubMed ID: 28044374
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant chemotherapy for patients with locally advanced gastric carcinoma: effect on tumor cell microinvolvement of regional lymph nodes.
    Becker K; Fumagalli U; Mueller JD; Fink U; Siewert JR; Höfler H
    Cancer; 1999 Apr; 85(7):1484-9. PubMed ID: 10193937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
    Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
    Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Value of Tumor Regression Grade Based on Ryan Score in Squamous Cell Carcinoma and Adenocarcinoma of Esophagus.
    Takeda FR; Tustumi F; de Almeida Obregon C; Yogolare GG; Navarro YP; Segatelli V; Sallum RAA; Junior UR; Cecconello I
    Ann Surg Oncol; 2020 Apr; 27(4):1241-1247. PubMed ID: 31664618
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
    Gervaz P; Rubbia-Brandt L; Andres A; Majno P; Roth A; Morel P; Mentha G
    Ann Surg Oncol; 2010 Oct; 17(10):2714-9. PubMed ID: 20405223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of regression of metastatic axillary lymph nodes after neoadjuvant chemotherapy in patients with breast cancer.
    Chung YR; Woo JW; Ahn S; Kang E; Kim EK; Jang M; Kim SM; Kim SH; Kim JH; Park SY
    Sci Rep; 2021 Jun; 11(1):12128. PubMed ID: 34108561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is the pathological regression level of metastatic lymph nodes associated with oncologic outcomes following preoperative chemoradiotherapy in rectal cancer?
    Choi JP; Kim SJ; Park IJ; Hong SM; Lee JL; Yoon YS; Kim CW; Lim SB; Lee JB; Yu CS; Kim JC
    Oncotarget; 2017 Feb; 8(6):10375-10384. PubMed ID: 28060748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumour regression grade (TRG) analyses in patients with resectable gastro-oesophageal adenocarcinomas treated with platinum-based neoadjuvant chemotherapy.
    Fareed KR; Ilyas M; Kaye PV; Soomro IN; Lobo DN; Parsons SL; Madhusudan S
    Histopathology; 2009 Oct; 55(4):399-406. PubMed ID: 19817890
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Debating deposits: an interobserver variability study of lymph nodes and pericolonic tumor deposits in colonic adenocarcinoma.
    Rock JB; Washington MK; Adsay NV; Greenson JK; Montgomery EA; Robert ME; Yantiss RK; Lehman AM; Frankel WL
    Arch Pathol Lab Med; 2014 May; 138(5):636-42. PubMed ID: 23902577
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Significance of histopathological tumor regression after neoadjuvant chemotherapy in gastric adenocarcinomas: a summary of 480 cases.
    Becker K; Langer R; Reim D; Novotny A; Meyer zum Buschenfelde C; Engel J; Friess H; Hofler H
    Ann Surg; 2011 May; 253(5):934-9. PubMed ID: 21490451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
    Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
    Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic Relevance of Lymph Node Regression After Neoadjuvant Chemoradiation for Esophageal Cancer.
    Philippron A; Bollschweiler E; Kunikata A; Plum P; Schmidt C; Favi F; Drebber U; Hölscher AH
    Semin Thorac Cardiovasc Surg; 2016 Summer; 28(2):549-558. PubMed ID: 28043475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. What Is the Ideal Tumor Regression Grading System in Rectal Cancer Patients after Preoperative Chemoradiotherapy?
    Kim SH; Chang HJ; Kim DY; Park JW; Baek JY; Kim SY; Park SC; Oh JH; Yu A; Nam BH
    Cancer Res Treat; 2016 Jul; 48(3):998-1009. PubMed ID: 26511803
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
    Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
    Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of different node staging systems in patients with ≤15 lymph nodes following surgery for gastric adenocarcinoma.
    Kılıç MÖ; Gündoğdu SB; Özden S; Saylam B; Tez M
    Acta Chir Belg; 2018 Feb; 118(1):1-6. PubMed ID: 28669280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-Associated Macrophages Extend Along Lymphatic Flow in the Pre-metastatic Lymph Nodes of Human Gastric Cancer.
    Go Y; Tanaka H; Tokumoto M; Sakurai K; Toyokawa T; Kubo N; Muguruma K; Maeda K; Ohira M; Hirakawa K
    Ann Surg Oncol; 2016 Feb; 23 Suppl 2():S230-5. PubMed ID: 25743331
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome.
    Wu TT; Chirieac LR; Abraham SC; Krasinskas AM; Wang H; Rashid A; Correa AM; Hofstetter WL; Ajani JA; Swisher SG
    Am J Surg Pathol; 2007 Jan; 31(1):58-64. PubMed ID: 17197919
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Schulz C; Kullmann F; Kunzmann V; Fuchs M; Geissler M; Vehling-Kaiser U; Stauder H; Wein A; Al-Batran SE; Kubin T; Schäfer C; Stintzing S; Giessen C; Modest DP; Ridwelski K; Heinemann V
    Int J Cancer; 2015 Aug; 137(3):678-85. PubMed ID: 25530271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of pathological response of primary tumor and metastatic axillary lymph nodes after neoadjuvant chemotherapy for locally advanced breast carcinoma.
    Machiavelli MR; Romero AO; Pérez JE; Lacava JA; Domínguez ME; Rodríguez R; Barbieri MR; Romero Acuña LA; Romero Acuña JM; Langhi MJ; Amato S; Ortiz EH; Vallejo CT; Leone BA
    Cancer J Sci Am; 1998; 4(2):125-31. PubMed ID: 9554929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.